Across Europe , interest surrounding copyright as a option for psychiatric conditions is surging. While historically viewed primarily as an veterinary agent, its efficacy in treating mood disorders, particularly chronic cases, is fueling a significant change in healthcare. Nevertheless , access stays complex and differs widely between member states